- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00158080
Hemofiltration for Contrast-Induced Nephropathy
September 7, 2005 updated by: Nara Medical University
Prevention of Contrast-Induced Nephropathy by Real-Time Hemofiltration
Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Koji Harada, MD
- Phone Number: 3411 +81-744-22-3051
- Email: kzharada@naramed-u.ac.jp
Study Locations
-
-
Nara
-
Kashihara, Nara, Japan, 634-8522
- Recruiting
- First Dept of InternalMedicine, Nara Medical University
-
Contact:
- Koji Harada, MD
- Phone Number: 3411 +81-744-22-3051
- Email: kzharada@naramed-u.ac.jp
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with serum creatinine>2.0mg/dl and/or GFR<50ml/min
Exclusion Criteria:
- Emergent cardiac catheterization
- Patients on chronic dialysis
- Patients with HYHA>III heart failure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Prevention of contrast-induced acute renal failure, Elevation of serum creatinine
|
Secondary Outcome Measures
Outcome Measure |
---|
Need for hemodialysis
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Yoshihiko Saito, MD, PhD, Nara Medical University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
September 7, 2005
First Submitted That Met QC Criteria
September 7, 2005
First Posted (Estimate)
September 12, 2005
Study Record Updates
Last Update Posted (Estimate)
September 12, 2005
Last Update Submitted That Met QC Criteria
September 7, 2005
Last Verified
September 1, 2005
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K0001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
-
Centre Hospitalier Saint Joseph Saint Luc de LyonNot yet recruitingKidney Failure, Chronic | Diet Habit | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 3B | Chronic Kidney Disease, Stage 3 (Moderate) | Chronic Kidney Disease Stage 3A (Disorder)France
-
A.C. AbrahamsCompletedEnd Stage Renal Disease | Chronic Kidney Disease | End Stage Kidney Disease | Chronic Kidney FailureNetherlands
-
Far Eastern Memorial HospitalActive, not recruitingMetabolic Syndrome | Chronic Disease | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 4 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on hemofiltration
-
University of SaskatchewanSaskatoon Health RegionCompletedCoronary Artery Disease | Heart Valve DiseasesCanada
-
Zhejiang UniversityCompletedOptimal Intensity of Renal Replacement Therapy on Sepsis PatientsChina
-
Hopital LariboisièreMinistry of Health, FranceCompletedSepsis | Gram-Negative Bacterial Infections | Gram-Positive Bacterial Infections | Shock, Septic | Bacteremia | Pneumonia, BacterialFrance
-
Instituto Nacional de Cardiologia Ignacio ChavezCompletedCognitive Impairment | Hemodialysis Complication | Cerebral Edema | Dialysis; ComplicationsMexico
-
Stanford UniversityUnknownRespiratory Insufficiency | Bone Marrow TransplantationUnited States, United Kingdom, Germany, Canada
-
Centre Hospitalier Universitaire de NīmesCompletedRenal Failure, AcuteFrance
-
A. Manzoni HospitalCompleted
-
University Hospital, GhentGambro Corporate Research, SwedenCompletedChronic Renal FailureBelgium
-
Air Force Military Medical University, ChinaUnknown
-
Onze Lieve Vrouwe GasthuisCompletedAcute Renal Failure | Multiple Organ Failure | KidneyNetherlands